Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Steinhart Richard I exercised options for 9,000 Bioxcel Therapeutics, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 7, 2026

On May 1, 2026, Steinhart Richard I (Chief Financial Officer) exercised options for 9,000 Bioxcel Therapeutics, Inc. shares, leaving 15,645 shares. Filed May 7, 2026 (Form 4).

Options exercised
9,000 shares
Holding after
15,645 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise9,00015,645Direct

Source

View original at SEC

Related